Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Paraneoplastic Syndromes

lenalidomide has been researched along with Paraneoplastic Syndromes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nohgawa, M; Oka, S; Ono, K1
Baiocchi, OCCG; Batista, MD; Enokihara, MMSES; Gomes, EE; Sato-Sano, M; Teixeira, SP; Vargas, JC1
Ko, C; Leventhal, J; Much, M; Stahl, M; Weed, J; Witt, D; Zeidan, AM1

Other Studies

3 other study(ies) available for lenalidomide and Paraneoplastic Syndromes

ArticleYear
Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.
    Journal of medical case reports, 2018, Oct-31, Volume: 12, Issue:1

    Topics: Aged, 80 and over; Bortezomib; Eosinophilia; Female; Humans; IgA Vasculitis; Immunologic Factors; Lenalidomide; Multiple Myeloma; Paraneoplastic Syndromes; Th1 Cells; Th2 Cells; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous

2018
Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.
    The Journal of dermatology, 2019, Volume: 46, Issue:7

    Topics: Eosinophilia; Exanthema; Humans; Lenalidomide; Lymphoma, Mantle-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pruritus; Skin; Treatment Outcome

2019
Reactive granulomatous dermatitis presenting as subcutaneous nodules and cords in a patient with advanced myelodysplastic syndrome.
    Annals of hematology, 2017, Volume: 96, Issue:6

    Topics: Aged; Blood Transfusion; Comorbidity; Fatal Outcome; Female; Granuloma; Histiocytes; Humans; Lenalidomide; Multiple Organ Failure; Myelodysplastic Syndromes; Neutrophils; Paraneoplastic Syndromes; Prednisone; Thalidomide

2017